The Effect of Phrenic Nerve Blockade on Acute and Chronic Shoulder Pain in Patients for Lobectomy and Pneumonectomy
NCT ID: NCT02173418
Last Updated: 2016-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
76 participants
INTERVENTIONAL
2012-11-30
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pulmonary Function and Interscalene Block
NCT02181296
Selective Block of the Axillary Nerve in Postoperative Pain Management
NCT01463865
A Novel Combination of Peripheral Nerve Blocks for Patients Scheduled for Shoulder Surgery
NCT02809144
Diaphragm-sparing Nerve Blocks for Shoulder Arthroplasty
NCT03877835
Suprascapular Nerve Block as Postoperative Analgesia After Artroscopic Shoulder Surgery
NCT02576223
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ropivacaine
Phrenic nerve block with Ropivacaine
Phrenic nerve block with Ropivacaine
Placebo
Phrenic nerve block with Sodium chloride
Phrenic nerve block with saline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Phrenic nerve block with Ropivacaine
Phrenic nerve block with saline
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. 18 years or more on the day of the operation
3. Danish skills appropriate for fulfilling preoperative questionnaires
Exclusion Criteria
2. Allergy to Ropivacaine or Sodium Chloride
3. Preoperative ipsilateral shoulder pain
4. Infection or eczema on the intervention site. Clinical decision
5. Dementia or similar cerebral condition that makes the subject unable to perform a NRS-score of pain. Determined by clinical evaluation
6. Pregnancy
7. Acute porphyria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Region of Southern Denmark
OTHER
University of Southern Denmark
OTHER
Læge Fritz Karners og hustrus Foundation
UNKNOWN
Overlæge dr. med. Edgar Schnohr og hustru Gilberte Schnohrs Foundation
UNKNOWN
Odense University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Morten Rune Blichfeldt-Eckhardt
Afdelingslæge
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Morten R Blichfeldt-Eckhardt, MD
Role: PRINCIPAL_INVESTIGATOR
Departement of anaesthesia and intensive care, Odense University Hospital, Odense, Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Departement of Anaesthesia and intensive care, Odense University Hospital
Odense, Region Syddanmark, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S-20120129
Identifier Type: OTHER
Identifier Source: secondary_id
2012-002844-25
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
2012-002844-25
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.